glp-1 therapy baton rouge for obesity Louisiana lawmakers are considering a bill that would expand Medicaid Oral GLP-1 Weight Loss |

While large-scale randomized controlled trials (RCTs) have focused on higher-dose protocols for regulatory approval, a growing number of physicians are reporting excellent results at significantly lower doses , especially in individuals who are metabolically healthy or seeking lifestyle optimization rather than aggressive weight loss

During early trials, the most common way to take this drug is a subcutaneous injection

GLP-1 medications should be stopped if pancreatitis develops, and should likely be avoided in anyone with pre-existing gastroparesis

We deliver physician-led, clinically-informed care trusted by members nationwide, with results that speak for themselves